These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 14379189)

  • 41. [Leukemias in rats produced by extracts of various human leukemic tissues].
    AGEENKO AI
    Vopr Onkol; 1961; 7(2)():9-19. PubMed ID: 13681604
    [No Abstract]   [Full Text] [Related]  

  • 42. Secondary leukemias in refractory germ cell tumor patients undergoing autologous stem-cell transplantation using high-dose etoposide.
    Houck W; Abonour R; Vance G; Einhorn LH
    J Clin Oncol; 2004 Jun; 22(11):2155-8. PubMed ID: 15169802
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of broad spectrum resistance of tumors towards anticancer drugs.
    Efferth T; Konkimalla VB; Wang YF; Sauerbrey A; Meinhardt S; Zintl F; Mattern J; Volm M
    Clin Cancer Res; 2008 Apr; 14(8):2405-12. PubMed ID: 18413831
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Studies on leukemia development in the SJL/J strain of mice.
    Haran-Ghera N; Kotler M; Meshorer A
    J Natl Cancer Inst; 1967 Oct; 39(4):653-61. PubMed ID: 18623927
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Experimental studies on anti-tumor effects of BLC-modified tumor cell vaccine combined with cisplatin].
    Zou CH; Tian L; Wei YQ; Zhao X; Kan B; Yang JL; Mao YQ; Wen YJ; Li J; Deng HX
    Ai Zheng; 2004 Jan; 23(1):1-7. PubMed ID: 14720366
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Experimental investigation of the etiopathogenesis of human leukemia. XII. Biological diagnosis of experimental leukemia by the virus interference test].
    MAS Y MAGRO F
    Arch Med Exp; 1954; 17(3):421-30. PubMed ID: 14377889
    [No Abstract]   [Full Text] [Related]  

  • 47. Lymphomas and leukemias in mice.
    Ward JM
    Exp Toxicol Pathol; 2006 Jul; 57(5-6):377-81. PubMed ID: 16713211
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and antiproliferative activity in vitro of novel (2-butynyl)thioquinolines.
    Mól W; Matyja M; Filip B; Wietrzyk J; Boryczka S
    Bioorg Med Chem; 2008 Sep; 16(17):8136-41. PubMed ID: 18682326
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy.
    Seshadri M; Spernyak JA; Mazurchuk R; Camacho SH; Oseroff AR; Cheney RT; Bellnier DA
    Clin Cancer Res; 2005 Jun; 11(11):4241-50. PubMed ID: 15930363
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Certain characteristics of metastatic spreading of experimental tumors].
    LOMAKIN MS
    Biull Eksp Biol Med; 1959 Jan; 47(1):62-6. PubMed ID: 13638290
    [No Abstract]   [Full Text] [Related]  

  • 51. [Pharmacodynamic tests of wulong kangai on transplantable tumors in mice].
    Liu YQ; Li CH; Yang GL; Chen H
    Zhongguo Zhong Yao Za Zhi; 2005 Nov; 30(21):1689-91. PubMed ID: 16400950
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Experimental hemopathy of the mouse, with aspect of lymphoid leukemia, homologously transmissible].
    AVEZZU G; PAGANELLI F
    Boll Soc Ital Biol Sper; 1954; 30(8-11):1157-60. PubMed ID: 14363465
    [No Abstract]   [Full Text] [Related]  

  • 53. Analysis of integrin signaling in genetically engineered mouse models of mammary tumor progression.
    Pylayeva Y; Guo W; Giancotti FG
    Methods Enzymol; 2007; 426():439-61. PubMed ID: 17697895
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Practices and pitfalls of mouse cancer models in drug discovery.
    Kung AL
    Adv Cancer Res; 2007; 96():191-212. PubMed ID: 17161681
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations.
    Mohi MG; Williams IR; Dearolf CR; Chan G; Kutok JL; Cohen S; Morgan K; Boulton C; Shigematsu H; Keilhack H; Akashi K; Gilliland DG; Neel BG
    Cancer Cell; 2005 Feb; 7(2):179-91. PubMed ID: 15710330
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors.
    Rachakatla RS; Marini F; Weiss ML; Tamura M; Troyer D
    Cancer Gene Ther; 2007 Oct; 14(10):828-35. PubMed ID: 17599089
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Experimental investigation on the etiopathogenesis of human lekemia. XI. Biological diagnosis of experimental leukemia by the test of induced constriction].
    MAS Y MAGRO F
    Arch Med Exp; 1954; 17(3):407-19. PubMed ID: 14377888
    [No Abstract]   [Full Text] [Related]  

  • 58. Correlation between VDR expression and antiproliferative activity of vitamin D3 compounds in combination with cytostatics.
    Pelczynska M; Wietrzyk J; Jaroszewicz I; Nevozhay D; Switalska M; Kutner A; Zabel M; Opolski A
    Anticancer Res; 2005; 25(3B):2235-40. PubMed ID: 16158969
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The requirement of multimodal therapy (vaccine, local tumor radiation, and reduction of suppressor cells) to eliminate established tumors.
    Kudo-Saito C; Schlom J; Camphausen K; Coleman CN; Hodge JW
    Clin Cancer Res; 2005 Jun; 11(12):4533-44. PubMed ID: 15958639
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effect of fluorine compounds on experimental tumors].
    SELLEI C; OLAH G; ECKHARDT S; KAPAS L
    Arch Geschwulstforsch; 1953; 5(3):263-4. PubMed ID: 13105316
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.